{"id":"tp-57059","type":"article-newspaper","title":"Evofem Biosciences Posts $2.63 Million in Q2 2026 Net Product Sales","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/57059","datePublished":"2026-11-13T22:28:10.000Z","dateModified":"2026-11-13T22:28:10.000Z","language":"en","abstract":"The company recorded an $11.144 million net loss attributable to common stockholders and a $0.08 loss per basic and diluted share. Management said cash and cash equivalents were insufficient to fund operations for at …","section":"Business","references":[]}